Moreover, to test the specificity of anti-STAU2, high percentages of positive T and B cells were not observed in various cancer types, including colon, bladder, oesophageal, liver, thyroid, ovarian, prostate and stomach cancer. Here, STAU2 is linked to gastric neoplasm.